Reasons to Add Stryker (SYK) Stock in Your Portfolio Now

Stryker Corporation (SYK) is well poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. Meanwhile, an improvement in price also buoys optimism.Shares of this Zacks Rank #2 (Buy) company have risen 17.9% year to date compared with the industry’s 4.1% growth. The S&P 500 Index has increased 8.3% in the same time frame.Stryker, with a market capitalization of $135.6 billion, is one of the world’s largest medical device companies operating in the ...